A Retrospective Study of Metastatic Lung Cancer Compression of the Cauda Equina

To the Editor:
Spinal cord compression by metastatic tumor is more commonly encountered than is compression of the cauda equina. 1 Lung cancer reportedly metastasizes more often to the thoracic segments of the spine than to other parts of the vertebral column. 2, 3 The paucity of data concerning patients' outcomes in cases of cauda equina compression by metastatic lung cancer (CEC-MLC) and the pervading interest in outcomes research prompted this retrospective study of patients.
From 1984 to 1997, 2,285 new cases of documented lung cancer were evaluated at two university-affiliated hospitals. From a review of the radiation oncology patient records, 16 cases (0.7%) of CEC-MLC were identified.
The diagnosis of compression of the cauda equina was based on clinical examination and radioimaging findings. Myelography was used more frequently than MRI to demonstrate the metastatic lesion and the thecal/neural sac compression.
CEC-MLC affected men more than women (Table 1) . Back pain and impaired muscle strength of the lower limbs were the predominant manifestations. The average duration of symptoms and signs of cauda equina compression was 89 days (range, 1 to 270 days). The most common histologic type of bronchogenic carcinoma was non-small cell cancer. The upper lobe of the lungs was affected the most. Ten patients had known metastatic disease elsewhere in the body. The lumbar segments of the cauda equina were mainly affected, rather than the sacral portions.
Treatment consisted of localized radiotherapy using a megavoltage photon beam from a 6-mV linear accelerator. The applied total dose was usually 30 Gy in 10 fractions, administered daily for 5 consecutive days. Corticosteroid medication, administered in a tapering fashion, was initiated as soon as the diagnosis of CEC-MLC was established. The achievement of palliation is shown in Table 2 . The overall average survival was 2 months (range 1 to 13 months). The poor prognosis observed in the present study is in accord with that noted by other investigators. 4 Tatsui and colleagues, 4 in evaluating survival of patients after the detection of spinal metastases, found that survival was shorter in individuals with lung cancer compared with survival of patients with breast cancer (3.6 Ϯ 6.1 months vs 29.4 Ϯ 33.5 months, respectively). *The numbers in parentheses indicate the numbers of evaluable patients.
In conclusion, it must be stated that the condition of CEC-MLC, though rare and associated with a grim prognosis, is amenable to effective palliation (as was determined in our small number of treated patients). 
Early Gene-Environment Interaction Into Asthma and Allergic Rhinitis Comorbidity
To the Editor:
Although there is undoubtedly a close relationship between asthma (A) and allergic rhinitis (AR) in individuals, 1 variations in the geographic distribution and epidemiologic associations of these two diseases have been described. 2 Yet, risk factors for the comorbidity of A and AR have been scarcely investigated.
The diagnosis of A and AR was assessed using a reduced version of the American Thoracic Society-Division of Lung Diseases-78 standardized questionnaire 3 in a population-based sample of 3,930 first-degree relatives obtained through 1,267 index children (age range, 3 months to 6 years) who were recruited during 1 month (1996) in four Italian cities (ie, Brindisi, Cagliari, Livorno, and Naples) [mean birth rate, 1.3%] through public health centers providing compulsory vaccinations. Familial aggregation of the comorbidity was investigated to estimate the relative influence of genetic factors and shared environmental events by using the generalized estimating equation type II model, which allows the taking of the nonindependence of data between first-degree relatives into account. 4 Data support the hypothesis of the alliance of genes and environment in the comorbidity of A and AR (Table 1 ). The aggregation of the comorbidity between AR and A was significantly more frequent among siblings than between parents and offspring. No significant aggregation was seen between parents. Relationships that were at variance were observed among parents who had AR only and among siblings who had A only.
The highest odds ratio (OR) that was found between siblings suggests that environmental factors, especially during childhood, might intervene in the development of the comorbidity of A and AR. The fact that a much stronger transmission of the comorbidity to the offspring by the mother (OR, 5.0; 95% confidence interval [CI], 2.2 to 11.4) than by the father (OR, 2.6; 95% CI, 1.2 to 6.0) also was observed seems to reinforce such a suggestion. A differential risk of transmission that is associated with the maternal phenotype already has been observed in the case of A. 5 Maternal transmission of an allergy could be explained by stronger maternal heritability, environmental events that affect the fetus, and the shared physical environment of mother and child.
Our findings provide epidemiologic evidence that early geneenvironment interaction is plausible in patients with comorbidity of A and AR. 
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